89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT

Florian Rosar, Mark Bartholomä, Stephan Maus, Bastiaan M Privé, Fadi Khreish, Gerben M Franssen, Yvonne H W Derks, James Nagarajah, Samer Ezziddin*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)

Abstract

For localization of biochemical recurrence of prostate cancer, 68Ga-PSMA-11 PET/CT imaging was performed in a 66-year-old man with no suspicious findings at 1 hour p.i. Additional 89Zr-PSMA-617 PET/CT revealed a small local recurrence in the prostate bed, facilitating consecutive local therapy. This interesting image points to the potential of PET/CT with 89Zr-labeled PSMA ligands, for example, 89Zr-PSMA-617, for identifying the source of biochemical recurrence despite otherwise negative imaging including conventional PSMA PET/CT.

Original languageEnglish
Pages (from-to)435-436
Number of pages2
JournalClinical Nuclear Medicine
Volume47
Issue number5
DOIs
Publication statusPublished - 1 May 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Fingerprint

Dive into the research topics of '89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT'. Together they form a unique fingerprint.

Cite this